Mon-Fri   9am-6pm

*Closed on Weekends

news

CDC Recommends Moderna Booster at 5 Months

​

CDC is adjusting our recommendation for when people can receive a booster shot, shortening the interval from 6 months to 5 months. Earlier this week CDC made this recommendation for recipients of a Pfizer-BioNTech primary series and we’re extending this recommendation to recipients of a Moderna primary series. This means that people who initially received an mRNA vaccine series – two doses of Moderna or Pfizer-BioNTech – can now receive an mRNA booster shot 5 months after completing their initial series.   

​

​

​

​

CDC Expands Booster Shot Eligibility and Strengthens Recommendations for 12-17 Year Olds

​

Today, CDC is endorsing the Advisory Committee on Immunization Practices’ (ACIP) recommendation to expand eligibility of booster doses to those 12 to 15 years old. CDC now recommends that adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series.

Data show that COVID-19 boosters help broaden and strengthen protection against Omicron and other SARS-CoV-2 variants. ACIP reviewed the available safety data following the administration of over 25 million vaccine doses in adolescents; COVID-19 vaccines are safe and effective.

At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for adolescents aged 12-17.